David Kearney
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $305 and has fallen 72.7% since, to $83 in 2023. That places this record below the midpoint for urology clinicians in MI, where the typical reported total is $2,586.
Across 49 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$129
- Blue Earth Diagnostics$108
- Myriad Genetic Laboratories, Inc.$106
- Johnson & Johnson$53
- Antares Pharma, Inc.$44
- AbbVie$39
- plus $407 from 17 others
What the payments were for
- Food & beverage$884100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 8 | $129 |
| Blue Earth Diagnostics | 5 | $108 |
| Myriad Genetic Laboratories, Inc. | 6 | $106 |
| Johnson & Johnson | 3 | $53 |
| Antares Pharma, Inc. | 2 | $44 |
| AbbVie | 2 | $39 |
| Dendreon Pharmaceuticals LLC | 2 | $38 |
| Merck | 2 | $38 |
| Tolmar Pharmaceuticals, Inc. | 2 | $37 |
| Coloplast | 2 | $34 |
| Cook Medical LLC | 2 | $33 |
| Endo Pharmaceuticals Inc. | 2 | $32 |
| Teleflex LLC | 1 | $25 |
| Urogen Pharma, Inc. | 1 | $25 |
| Axonics, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Baudax Bio Inc. | 1 | $18 |
| Convatec Inc. | 1 | $17 |
| Urovant Sciences Inc | 1 | $16 |
| Bayer | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $2 |
How this compares
$887 in reported general payments places this provider in the 30th percentile of 400 urology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Finasteride | 44 | $1,005 |
| Tamsulosin Hcl | 24 | $381 |
Paid to pharmacies, not to this prescriber.
Other urology in Troy
- Kenneth KernenTroy$910K
- Ashok ReddySterling Heights$4.9M
- William RobertsAnn Arbor$973K
- William JohnstonLivonia$675K
- Jason HafronWest Bloomfield$490K
- Khurshid GhaniAnn Arbor$413K
- Richard BennettRoyal Oak$361K
- Ryan NelsonUtica$296K
- Casey DauwAnn Arbor$188K
- Aram LoebDetroit$112K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.